SCL Science Inc. (KOSDAQ: 246960)
South Korea
· Delayed Price · Currency is KRW
8,100.00
-30.00 (-0.37%)
Nov 15, 2024, 9:00 AM KST
SCL Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 3,059 | 1,322 | 369.78 | 507.29 | 596.19 | 692.76 | Upgrade
|
Other Revenue | -0 | -0 | -0 | - | - | - | Upgrade
|
Revenue | 3,059 | 1,322 | 369.78 | 507.29 | 596.19 | 692.76 | Upgrade
|
Revenue Growth (YoY) | 389.14% | 257.54% | -27.11% | -14.91% | -13.94% | 35.25% | Upgrade
|
Cost of Revenue | 2,021 | 1,114 | 301.37 | 323.79 | 256.86 | 328.25 | Upgrade
|
Gross Profit | 1,038 | 208.41 | 68.41 | 183.49 | 339.33 | 364.51 | Upgrade
|
Selling, General & Admin | 2,745 | 2,662 | 3,037 | 3,092 | 2,637 | 3,169 | Upgrade
|
Research & Development | 1,235 | 1,235 | 1,338 | 1,423 | 1,239 | 958.36 | Upgrade
|
Operating Expenses | 4,358 | 4,226 | 4,673 | 4,721 | 4,037 | 4,265 | Upgrade
|
Operating Income | -3,319 | -4,017 | -4,605 | -4,538 | -3,697 | -3,901 | Upgrade
|
Interest Expense | -425.46 | -730.77 | -874.14 | -564.67 | -55.49 | -29.14 | Upgrade
|
Interest & Investment Income | 143.28 | 141.07 | 170.34 | 99.68 | 96.96 | 224.69 | Upgrade
|
Earnings From Equity Investments | -717.7 | -2,988 | -67.31 | 217.1 | 265.21 | -281.29 | Upgrade
|
Currency Exchange Gain (Loss) | -3.11 | -9.53 | -7.42 | 1.74 | -9.96 | -1.5 | Upgrade
|
Other Non Operating Income (Expenses) | 2,566 | 2,860 | -567.49 | -234.68 | 2.75 | -0.53 | Upgrade
|
EBT Excluding Unusual Items | -1,757 | -4,744 | -5,951 | -5,019 | -3,398 | -3,988 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | 29.8 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -27.41 | -63.87 | 0.02 | -10.38 | 108.92 | - | Upgrade
|
Asset Writedown | -32.8 | -215.19 | -33.34 | -14.21 | - | - | Upgrade
|
Pretax Income | -1,817 | -5,023 | -5,984 | -5,013 | -3,289 | -3,988 | Upgrade
|
Income Tax Expense | 13.33 | 2.08 | -12.42 | 26.54 | -252.8 | 0.58 | Upgrade
|
Earnings From Continuing Operations | -1,830 | -5,026 | -5,972 | -5,040 | -3,036 | -3,989 | Upgrade
|
Minority Interest in Earnings | - | -0.72 | 0.1 | 10.74 | -11.38 | 0.09 | Upgrade
|
Net Income | -1,830 | -5,026 | -5,972 | -5,029 | -3,047 | -3,989 | Upgrade
|
Net Income to Common | -1,830 | -5,026 | -5,972 | -5,029 | -3,047 | -3,989 | Upgrade
|
Shares Outstanding (Basic) | 7 | 6 | 5 | 5 | 5 | 5 | Upgrade
|
Shares Outstanding (Diluted) | 7 | 6 | 5 | 5 | 5 | 5 | Upgrade
|
Shares Change (YoY) | 20.42% | 18.93% | 4.73% | - | 1.20% | 21.06% | Upgrade
|
EPS (Basic) | -265.55 | -800.03 | -1130.46 | -997.03 | -604.15 | -800.30 | Upgrade
|
EPS (Diluted) | -265.55 | -800.03 | -1130.46 | -997.03 | -604.15 | -800.30 | Upgrade
|
Free Cash Flow | -5,590 | -5,194 | -4,445 | -10,326 | -4,690 | -3,549 | Upgrade
|
Free Cash Flow Per Share | -811.05 | -826.69 | -841.34 | -2047.16 | -929.81 | -712.08 | Upgrade
|
Gross Margin | 33.95% | 15.76% | 18.50% | 36.17% | 56.92% | 52.62% | Upgrade
|
Operating Margin | -108.52% | -303.85% | -1245.36% | -894.52% | -620.15% | -563.06% | Upgrade
|
Profit Margin | -59.83% | -380.17% | -1614.99% | -991.39% | -511.16% | -575.80% | Upgrade
|
Free Cash Flow Margin | -182.74% | -392.84% | -1201.95% | -2035.58% | -786.69% | -512.33% | Upgrade
|
EBITDA | -2,386 | -3,217 | -3,849 | -3,865 | -3,155 | -3,478 | Upgrade
|
EBITDA Margin | -78.02% | -243.31% | - | - | - | - | Upgrade
|
D&A For EBITDA | 933.01 | 800.4 | 756.35 | 673.08 | 542.17 | 422.3 | Upgrade
|
EBIT | -3,319 | -4,017 | -4,605 | -4,538 | -3,697 | -3,901 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.